[Iodine-125 interstitial brachytherapy for malignant tumor].
OBJECTIVE
To assess the clinical effects of (125)I interstitial brachytherapy for malignant tumors.


METHODS
One hundred and twelve patients with malignant tumors of stage II stage and III under went radical resection combined with (125)I intraoperative implantation. Seven days and three month after operation WBC count and immune markers were observed. Blood biochemistry ultrasonography and X-ray were performed to observe recurrence and metastasis of tumors per three months.


RESULTS
In the 112 patients, 3 died of tumor recurrence in six months, and others survived with the longest time of 35 months.


CONCLUSIONS
(125)I interstitial brachytherapy for malignant tumor is simple, safe and effective.
Luo
Kai-yuan
KY
Department of General Surgery, Second People's Hospital, Yunnan Province, Kunming 650021, China.
Mao
Wen-yuan
WY
Li
Bo
B
Shao
Qing-hua
QH
Yang
Yong
Y
Zhao
Quan
Q
Yang
Rong
R
Yang
Guo-kai
GK
D000328:Adult; D000368:Aged; D001918:Brachytherapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy; D012189:Retrospective Studies; D016896:Treatment Outcome
D007457:Iodine Radioisotopes